Back to Browse Journals » OncoTargets and Therapy » Volume 10

OncoTargets and Therapy


Archive: Volume 10, 2017

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection

Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM

OncoTargets and Therapy 2017, 10:2257-2266

Published Date: 21 April 2017

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer

Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z

OncoTargets and Therapy 2017, 10:2249-2256

Published Date: 21 April 2017

PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro

Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X

OncoTargets and Therapy 2017, 10:2239-2247

Published Date: 20 April 2017

Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer

Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2227-2237

Published Date: 20 April 2017

NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo

Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y

OncoTargets and Therapy 2017, 10:2219-2226

Published Date: 19 April 2017

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer

Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ

OncoTargets and Therapy 2017, 10:2209-2217

Published Date: 19 April 2017

Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients

You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z

OncoTargets and Therapy 2017, 10:2199-2208

Published Date: 18 April 2017

Novel insights into circular RNAs in clinical application of carcinomas

Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H

OncoTargets and Therapy 2017, 10:2183-2188

Published Date: 18 April 2017

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F

OncoTargets and Therapy 2017, 10:2173-2181

Published Date: 18 April 2017

Monosomal karyotype in myeloid neoplasias: a literature review

Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F

OncoTargets and Therapy 2017, 10:2163-2171

Published Date: 20 April 2017

Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection

Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D

OncoTargets and Therapy 2017, 10:2155-2162

Published Date: 13 April 2017

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy

Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2147-2154

Published Date: 12 April 2017

Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells

Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X

OncoTargets and Therapy 2017, 10:2139-2146

Published Date: 12 April 2017

miR-762 can negatively regulate menin in ovarian cancer

Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L

OncoTargets and Therapy 2017, 10:2127-2137

Published Date: 12 April 2017

A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway

Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C

OncoTargets and Therapy 2017, 10:2115-2126

Published Date: 12 April 2017

Gastric cancer, nutritional status, and outcome

Liu X, Qiu H, Kong P, Zhou Z, Sun X

OncoTargets and Therapy 2017, 10:2107-2114

Published Date: 12 April 2017

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Wagner LM, Adams VR

OncoTargets and Therapy 2017, 10:2097-2106

Published Date: 12 April 2017

Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors

Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S

OncoTargets and Therapy 2017, 10:2077-2085

Published Date: 12 April 2017

Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients

Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC

OncoTargets and Therapy 2017, 10:2069-2075

Published Date: 10 April 2017

The role of KPNβ1 in neuro-oncology

Lilley M, Farassati F

OncoTargets and Therapy 2017, 10:2067-2068

Published Date: 10 April 2017

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7

Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J

OncoTargets and Therapy 2017, 10:2045-2056

Published Date: 7 April 2017

Expression and significance of GRHL2 in esophageal cancer

Shao CC, Ji CS, Wang XQ, Hu B

OncoTargets and Therapy 2017, 10:2025-2031

Published Date: 7 April 2017

REG3A promotes the proliferation, migration, and invasion of gastric cancer cells

Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF

OncoTargets and Therapy 2017, 10:2017-2023

Published Date: 6 April 2017

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients

Chen J, Li H, Pang RL, Huang J

OncoTargets and Therapy 2017, 10:2003-2007

Published Date: 6 April 2017

Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer

Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ

OncoTargets and Therapy 2017, 10:1993-2002

Published Date: 6 April 2017

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A

OncoTargets and Therapy 2017, 10:1983-1992

Published Date: 6 April 2017

Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation

Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF

OncoTargets and Therapy 2017, 10:1977-1982

Published Date: 4 April 2017

HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population

Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC

OncoTargets and Therapy 2017, 10:1969-1975

Published Date: 4 April 2017

Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer

Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q

OncoTargets and Therapy 2017, 10:1947-1954

Published Date: 3 April 2017

Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line

Attar R, Cincin ZB, Bireller ES, Cakmakoglu B

OncoTargets and Therapy 2017, 10:1941-1946

Published Date: 31 March 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:1933-1939

Published Date: 30 March 2017

Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane

Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:1921-1932

Published Date: 30 March 2017

Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication

Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q

OncoTargets and Therapy 2017, 10:1915-1920

Published Date: 29 March 2017

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia

Khan M, Gibbons JL, Ferrajoli A

OncoTargets and Therapy 2017, 10:1909-1914

Published Date: 29 March 2017

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis

Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH

OncoTargets and Therapy 2017, 10:1897-1908

Published Date: 29 March 2017

Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis

Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A

OncoTargets and Therapy 2017, 10:1889-1896

Published Date: 29 March 2017

Genetic variants and increased risk of meningioma: an updated meta-analysis

Han X, Wang W, Wang L, Wang X, Li G

OncoTargets and Therapy 2017, 10:1875-1888

Published Date: 28 March 2017

DNMT1 regulates human endometrial carcinoma cell proliferation

Wang X, Li B

OncoTargets and Therapy 2017, 10:1865-1873

Published Date: 29 March 2017

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K

OncoTargets and Therapy 2017, 10:1859-1863

Published Date: 28 March 2017

Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature

Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z

OncoTargets and Therapy 2017, 10:1853-1858

Published Date: 27 March 2017

Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis

Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L

OncoTargets and Therapy 2017, 10:1843-1852

Published Date: 27 March 2017

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial

Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G

OncoTargets and Therapy 2017, 10:1835-1842

Published Date: 24 March 2017

Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression

Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y

OncoTargets and Therapy 2017, 10:1827-1834

Published Date: 23 March 2017

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Song Z, Yu X, Lou G, Shi X, Zhang Y

OncoTargets and Therapy 2017, 10:1821-1825

Published Date: 23 March 2017

Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy

Robainas M, Otano R, Bueno S, Ait-Oudhia S

OncoTargets and Therapy 2017, 10:1803-1807

Published Date: 23 March 2017

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J

OncoTargets and Therapy 2017, 10:1793-1801

Published Date: 23 March 2017

Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis

Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J

OncoTargets and Therapy 2017, 10:1777-1781

Published Date: 23 March 2017

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G

OncoTargets and Therapy 2017, 10:1767-1776

Published Date: 23 March 2017

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W

OncoTargets and Therapy 2017, 10:1743-1755

Published Date: 22 March 2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

OncoTargets and Therapy 2017, 10:1735-1742

Published Date: 21 March 2017

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:1709-1710

Published Date: 21 March 2017

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]

Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC

OncoTargets and Therapy 2017, 10:1707-1708

Published Date: 21 March 2017

Primary pancreatic lymphoma: two case reports and a literature review

Yu L, Chen Y, Xing L

OncoTargets and Therapy 2017, 10:1687-1694

Published Date: 20 March 2017

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma

Ning X, Deng Y

OncoTargets and Therapy 2017, 10:1673-1686

Published Date: 20 March 2017

Role of cytokines and chemokines in alcohol-induced tumor promotion

Chen D, Zhang F, Ren H, Luo J, Wang S

OncoTargets and Therapy 2017, 10:1665-1671

Published Date: 17 March 2017

CDKL1 promotes tumor proliferation and invasion in colorectal cancer

Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J

OncoTargets and Therapy 2017, 10:1613-1624

Published Date: 16 March 2017

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling

Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L

OncoTargets and Therapy 2017, 10:1603-1611

Published Date: 14 March 2017

SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis

Zhang X, Fan Y, Li Z

OncoTargets and Therapy 2017, 10:1575-1583

Published Date: 14 March 2017

Mechanism of immune evasion in breast cancer

Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y

OncoTargets and Therapy 2017, 10:1561-1573

Published Date: 14 March 2017

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study

Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J

OncoTargets and Therapy 2017, 10:1535-1548

Published Date: 13 March 2017

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma

Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK

OncoTargets and Therapy 2017, 10:1527-1533

Published Date: 13 March 2017

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report

Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J

OncoTargets and Therapy 2017, 10:1521-1525

Published Date: 13 March 2017

MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]

Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J

OncoTargets and Therapy 2017, 10:1519-1520

Published Date: 10 March 2017

Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer

Sang Y, Bi X, Liu Y, Zhang W, Wang D

OncoTargets and Therapy 2017, 10:1513-1518

Published Date: 10 March 2017

Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells

Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z

OncoTargets and Therapy 2017, 10:1503-1512

Published Date: 9 March 2017

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM

OncoTargets and Therapy 2017, 10:1487-1502

Published Date: 9 March 2017

Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors

Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT

OncoTargets and Therapy 2017, 10:1475-1485

Published Date: 8 March 2017

Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors

Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z

OncoTargets and Therapy 2017, 10:1465-1474

Published Date: 7 March 2017

Chronological changes in lung cancer surgery in a single Japanese institution

Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H

OncoTargets and Therapy 2017, 10:1459-1464

Published Date: 6 March 2017

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer

Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM

OncoTargets and Therapy 2017, 10:1451-1457

Published Date: 6 March 2017

Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma

Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z

OncoTargets and Therapy 2017, 10:1441-1449

Published Date: 6 March 2017

GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis

Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M

OncoTargets and Therapy 2017, 10:1433-1440

Published Date: 6 March 2017

MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK

Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z

OncoTargets and Therapy 2017, 10:1423-1431

Published Date: 6 March 2017

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO

OncoTargets and Therapy 2017, 10:1403-1412

Published Date: 3 March 2017

Arterial stiffness in hematologic malignancies

Mozos I, Borzak G, Caraba A, Mihaescu R

OncoTargets and Therapy 2017, 10:1381-1388

Published Date: 3 March 2017

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks

Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N

OncoTargets and Therapy 2017, 10:1375-1380

Published Date: 3 March 2017

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma

Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D

OncoTargets and Therapy 2017, 10:1363-1373

Published Date: 3 March 2017

125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy:a comparison with best supportive care

Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J

OncoTargets and Therapy 2017, 10:1345-1352

Published Date: 2 March 2017

Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?

Kong X, Kong Y

OncoTargets and Therapy 2017, 10:1335-1344

Published Date: 1 March 2017

Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients

Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X

OncoTargets and Therapy 2017, 10:1285-1294

Published Date: 28 February 2017

MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis

Cai H, Chen X, Tang Y, Deng Y

OncoTargets and Therapy 2017, 10:1269-1278

Published Date: 28 February 2017

Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo

Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q

OncoTargets and Therapy 2017, 10:1261-1267

Published Date: 28 February 2017

miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma

Luan WK, Qian Y, Ni X, Bu XF, Xia Y, Wang JL, Ruan HR, Ma SJ, Xu B

OncoTargets and Therapy 2017, 10:1237-1246

Published Date: 27 February 2017

Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women

Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1207-1216

Published Date: 24 February 2017

Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort

Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X

OncoTargets and Therapy 2017, 10:1199-1206

Published Date: 24 February 2017

Aberrant histone modification in CD19+ B cells of the patients with chronic lymphocytic leukemia

Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y

OncoTargets and Therapy 2017, 10:1173-1179

Published Date: 23 February 2017

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T

OncoTargets and Therapy 2017, 10:1155-1164

Published Date: 23 February 2017

Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population

Fu W, Zhuo Z, Jia W, Zhu J, Zhu S, Lin Z, Wang F, Xia H, He J, Liu G

OncoTargets and Therapy 2017, 10:1149-1154

Published Date: 23 February 2017

Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T

OncoTargets and Therapy 2017, 10:1143-1147

Published Date: 23 February 2017

Intrahepatic cholangiocarcinoma: current perspectives

Buettner S, van Vugt JLA, IJzermans JNM, Groot Koerkamp B

OncoTargets and Therapy 2017, 10:1131-1142

Published Date: 22 February 2017

Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study

Zhao YX, Liu S, Hu YB, Ge YY, Lv DM

OncoTargets and Therapy 2017, 10:1123-1129

Published Date: 22 February 2017

Internal mammary lymph node management – further direction

Vrana D, Gatek J

OncoTargets and Therapy 2017, 10:1111-1114

Published Date: 21 February 2017

Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer

Sheng J, Fang W, Liu X, Xing S, Zhan J, Ma Y, Huang Y, Zhou N, Zhao H, Zhang L

OncoTargets and Therapy 2017, 10:1101-1110

Published Date: 21 February 2017

Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells

Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang C, Zhao W

OncoTargets and Therapy 2017, 10:1091-1100

Published Date: 22 February 2017

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Guetz S, Tufman A, von Pawel J, Rittmeyer A, Borgmeier A, Ferré P, Edlich B, Huber RM

OncoTargets and Therapy 2017, 10:1081-1089

Published Date: 21 February 2017

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma

Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H

OncoTargets and Therapy 2017, 10:1039-1047

Published Date: 20 February 2017

miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1

Zheng L, Chen J, Zhou Z, He Z

OncoTargets and Therapy 2017, 10:1027-1038

Published Date: 20 February 2017

Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells

Mang YY, Li L, Ran JH, Zhang SN, Liu J, Li LB, Chen YM, Liu J, Gao Y, Ren G

OncoTargets and Therapy 2017, 10:1003-1016

Published Date: 20 February 2017

Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]

Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T

OncoTargets and Therapy 2017, 10:1001-1002

Published Date: 21 February 2017

Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis

Chen T, Wang H, Yang P, He ZY

OncoTargets and Therapy 2017, 10:993-1000

Published Date: 17 February 2017

Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study

Farzaneh E, Heydari H, Shekarchi AA, Kamran A

OncoTargets and Therapy 2017, 10:985-992

Published Date: 17 February 2017

Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis

Yi SY, Zeng LJ, Kuang Y, Cao ZJ, Zheng CJ, Zhang Y, Liao M, Yang L

OncoTargets and Therapy 2017, 10:973-984

Published Date: 17 February 2017

BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study

Cohn AL, Day B, Abhyankar S, McKenna E, Riehl T, Puzanov I

OncoTargets and Therapy 2017, 10:965-971

Published Date: 17 February 2017

Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor

Zhu S, Liu G, Fu W, Hu J, Fu K, Jia W

OncoTargets and Therapy 2017, 10:955-963

Published Date: 16 February 2017

Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis

Hao Y, Fu Q, Guo Y, Ye M, Zhao H, Wang Q, Peng X, Li Q, Wang R, Xiao W

OncoTargets and Therapy 2017, 10:945-953

Published Date: 16 February 2017

The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer

Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X

OncoTargets and Therapy 2017, 10:927-933

Published Date: 16 February 2017

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis

Lan X, Li S, Gao H, Nanding A, Quan L, Yang C, Ding S, Xue Y

OncoTargets and Therapy 2017, 10:919-926

Published Date: 16 February 2017

Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy

Tan JY, Jiang L, Cheng XW, Wang CL, Chen JS, Huang XQ, Xie P, Xia DM, Wang RS, Zhang Y

OncoTargets and Therapy 2017, 10:909-918

Published Date: 15 February 2017

Carfilzomib boosted combination therapy for relapsed multiple myeloma

Steiner RE, Manasanch EE

OncoTargets and Therapy 2017, 10:895-907

Published Date: 15 February 2017

miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma

Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S

OncoTargets and Therapy 2017, 10:885-894

Published Date: 15 February 2017

Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma

Yu S, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang X

OncoTargets and Therapy 2017, 10:879-884

Published Date: 15 February 2017

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy

Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J

OncoTargets and Therapy 2017, 10:871-877

Published Date: 14 February 2017

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis

Li Z, Yin SC, Zhang L, Liu WG, Chen B, Xing H

OncoTargets and Therapy 2017, 10:859-870

Published Date: 14 February 2017

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series

Zhang H, Chen F, Wang Z, Wu S

OncoTargets and Therapy 2017, 10:837-845

Published Date: 14 February 2017

The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma

Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H

OncoTargets and Therapy 2017, 10:819-835

Published Date: 14 February 2017

AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway

Chen JJ, Wang ZJ, Yu SS

OncoTargets and Therapy 2017, 10:811-817

Published Date: 13 February 2017

RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1

Guo Y, Zhang PD, Zhang HT, Zhang P, Xu RX

OncoTargets and Therapy 2017, 10:791-801

Published Date: 13 February 2017

Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma

Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L

OncoTargets and Therapy 2017, 10:781-790

Published Date: 13 February 2017

Efficacy of eribulin in breast cancer: a short report on the emerging new data

Eslamian G, Wilson C, Young RJ

OncoTargets and Therapy 2017, 10:773-779

Published Date: 13 February 2017

Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma

Zhang W, Pang Q, Yan C, Wang Q, Yang J, Yu S, Liu X, Yuan Z, Wang P, Xiao Z

OncoTargets and Therapy 2017, 10:763-771

Published Date: 13 February 2017

MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1

Wang J, Tang W, Liao M, Liu Y, Ai X

OncoTargets and Therapy 2017, 10:753-761

Published Date: 10 February 2017

Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia

Kohailan M, Alanazi M, Rouabhia M, Al Amri A, Parine NR, Semlali A

OncoTargets and Therapy 2017, 10:745-752

Published Date: 9 February 2017

Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma

Xu WZ, Li F, Xu ZK, Chen X, Sun B, Cao JW, Liu YG

OncoTargets and Therapy 2017, 10:725-733

Published Date: 8 February 2017

β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma

Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD

OncoTargets and Therapy 2017, 10:711-724

Published Date: 20 February 2017

Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population

Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H

OncoTargets and Therapy 2017, 10:703-709

Published Date: 8 February 2017

ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines

Li JP, Liu Y, Yin YH

OncoTargets and Therapy 2017, 10:691-701

Published Date: 7 February 2017

miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1

Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG

OncoTargets and Therapy 2017, 10:667-679

Published Date: 7 February 2017

Prognostic implications of Kindlin proteins in human osteosarcoma

Ning K, Zhang H, Wang Z, Li K

OncoTargets and Therapy 2017, 10:657-665

Published Date: 7 February 2017

Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia

Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S

OncoTargets and Therapy 2017, 10:645-656

Published Date: 7 February 2017

Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway

Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T

OncoTargets and Therapy 2017, 10:627-643

Published Date: 3 February 2017

FLT3 inhibitors: clinical potential in acute myeloid leukemia

Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J

OncoTargets and Therapy 2017, 10:607-615

Published Date: 3 February 2017

Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase

Alakel N, Middeke JM, Schetelig J, Bornhäuser M

OncoTargets and Therapy 2017, 10:597-605

Published Date: 2 February 2017

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K

OncoTargets and Therapy 2017, 10:591-596

Published Date: 2 February 2017

Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents

Yang HL, Song EL, Shen GR, Zhu TH, Jiang TW, Shen H, Niu LP, Wang B, Lu ZY, Qian JP

OncoTargets and Therapy 2017, 10:579-590

Published Date: 2 February 2017

Exploring targeted therapy of osteosarcoma using proteomics data

Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D

OncoTargets and Therapy 2017, 10:565-577

Published Date: 1 February 2017

Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung

Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A

OncoTargets and Therapy 2017, 10:559-564

Published Date: 31 January 2017

Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life

Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G

OncoTargets and Therapy 2017, 10:551-557

Published Date: 27 January 2017

miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer

Yang F, Li Y, Xu L, Zhu Y, Gao H, Zhen L, Fang L

OncoTargets and Therapy 2017, 10:543-550

Published Date: 27 January 2017

Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer

Shao Q, Liu S, Wang W, zhang Y, Li F, Li J

OncoTargets and Therapy 2017, 10:535-541

Published Date: 31 January 2017

The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma

Zhong GX, Feng SD, Shen RK, Wu Z, Chen F, Zhu X

OncoTargets and Therapy 2017, 10:527-533

Published Date: 8 February 2017

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease

Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M

OncoTargets and Therapy 2017, 10:521-526

Published Date: 24 January 2017

Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma

Wahid M, Jawed A, Dar SA, Mandal RK, Haque S

OncoTargets and Therapy 2017, 10:515-520

Published Date: 24 January 2017

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF

OncoTargets and Therapy 2017, 10:503-514

Published Date: 23 January 2017

Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis

Wang J, Yu M, Guan S, Zhang G, Wang J, Cheng Y

OncoTargets and Therapy 2017, 10:493-502

Published Date: 23 January 2017

Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis

Shen SD, Zhong SZ, Xiao GF, Zhou HB, Huang WH

OncoTargets and Therapy 2017, 10:477-481

Published Date: 21 January 2017

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K

OncoTargets and Therapy 2017, 10:463-476

Published Date: 21 January 2017

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis

Liu W, Wang X, Sun J, Yang Y, Li W, Song J

OncoTargets and Therapy 2017, 10:453-461

Published Date: 23 January 2017

Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma

Fang S, Zhang H, Zhang Y, Xie W

OncoTargets and Therapy 2017, 10:447-452

Published Date: 18 January 2017

Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel

Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z

OncoTargets and Therapy 2017, 10:439-446

Published Date: 18 January 2017

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status

Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K

OncoTargets and Therapy 2017, 10:429-437

Published Date: 18 January 2017

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis

Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX

OncoTargets and Therapy 2017, 10:417-428

Published Date: 18 January 2017

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF

OncoTargets and Therapy 2017, 10:409-415

Published Date: 18 January 2017

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature

Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC

OncoTargets and Therapy 2017, 10:397-407

Published Date: 18 January 2017

FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma

Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L

OncoTargets and Therapy 2017, 10:387-395

Published Date: 16 January 2017

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J

OncoTargets and Therapy 2017, 10:371-385

Published Date: 16 January 2017

Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma

Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y

OncoTargets and Therapy 2017, 10:363-370

Published Date: 13 January 2017

Advances in antiangiogenic treatment of small-cell lung cancer

Lu H, Jiang Z

OncoTargets and Therapy 2017, 10:353-359

Published Date: 12 January 2017

Chidamide in the treatment of peripheral T-cell lymphoma

Chan TS, Tse E, Kwong YL

OncoTargets and Therapy 2017, 10:347-352

Published Date: 12 January 2017

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy

Chen J, Liu L, Xu J

OncoTargets and Therapy 2017, 10:339-345

Published Date: 11 January 2017

Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice

Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D

OncoTargets and Therapy 2017, 10:329-338

Published Date: 11 January 2017

Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM

OncoTargets and Therapy 2017, 10:319-327

Published Date: 10 January 2017

Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor

Sun F, Li W, Wang L, Jiao C

OncoTargets and Therapy 2017, 10:311-317

Published Date: 10 January 2017

Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis

Jiang S, Xu J, Zhuo Z, Hua Z

OncoTargets and Therapy 2017, 10:303-310

Published Date: 10 January 2017

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z

OncoTargets and Therapy 2017, 10:295-302

Published Date: 10 January 2017

Correlation of SASH1 expression and ultrasonographic features in breast cancer

Gong X, Wu J, Wu J, Liu J, Gu H, Shen H

OncoTargets and Therapy 2017, 10:271-276

Published Date: 10 January 2017

Strategies of temozolomide in future glioblastoma treatment

Lee CY

OncoTargets and Therapy 2017, 10:265-270

Published Date: 9 January 2017

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY

OncoTargets and Therapy 2017, 10:247-257

Published Date: 9 January 2017

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H

OncoTargets and Therapy 2017, 10:239-245

Published Date: 6 January 2017

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G

OncoTargets and Therapy 2017, 10:217-226

Published Date: 6 January 2017

Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer

Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H

OncoTargets and Therapy 2017, 10:205-216

Published Date: 5 January 2017

Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas

He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H

OncoTargets and Therapy 2017, 10:195-203

Published Date: 4 January 2017

The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer

Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ

OncoTargets and Therapy 2017, 10:185-194

Published Date: 29 December 2016

Pediatric papillary thyroid cancer: current management challenges

Verburg FA, Van Santen HM, Luster M

OncoTargets and Therapy 2017, 10:165-175

Published Date: 28 December 2016

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

OncoTargets and Therapy 2017, 10:153-163

Published Date: 28 December 2016

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma

Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X

OncoTargets and Therapy 2017, 10:145-151

Published Date: 22 December 2016

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

OncoTargets and Therapy 2017, 10:137-144

Published Date: 22 December 2016

High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma

Yan H, Tian R, Zhang M, Wu J, Ding M, He J

OncoTargets and Therapy 2017, 10:113-120

Published Date: 21 December 2016

Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study

Wang Y, Meng F, Liu Y, Chen X

OncoTargets and Therapy 2017, 10:95-100

Published Date: 20 December 2016

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:85-94

Published Date: 20 December 2016

RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src

Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y

OncoTargets and Therapy 2017, 10:73-83

Published Date: 5 January 2017

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL

OncoTargets and Therapy 2017, 10:67-72

Published Date: 20 December 2016

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma

Cheng Y, Xing SG, Jia WD, Huang M, Bian NN

OncoTargets and Therapy 2017, 10:47-54

Published Date: 19 December 2016

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP

Lei R, Xue M, Zhang L, Lin ZQ

OncoTargets and Therapy 2017, 10:35-46

Published Date: 19 December 2016

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report

Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M

OncoTargets and Therapy 2017, 10:31-34

Published Date: 19 December 2016

Potential role of immunotherapy in advanced non-small-cell lung cancer

de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G

OncoTargets and Therapy 2017, 10:21-30

Published Date: 16 December 2016

J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)

Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K

OncoTargets and Therapy 2017, 10:13-19

Published Date: 16 December 2016

Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients

Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1-11

Published Date: 16 December 2016